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journal homepage: www.e lsev ier .com/ locate /yse izThis article was an interesting one to investigate, as the topic
evoked much lively discussion among the colleagues and
acquaintances from whom I sought to gain a broad range of
opinions. The groups from which my discussants came were
varied, as were their backgrounds and ages. Each individual
however was very passionate about their particular point of view.
Those asked for their opinions included: people with epilepsy,
living with the condition every day; a healthcare provider working
in the social care sector; a teacher/support worker working with
learning disability service users; a staff development manager
responsible for accessing high-quality staff training; and a carer of
a person with epilepsy living at home in a domestic setting. So – a
diverse group, each with a different perspective, but highlighting
some common ground where they felt progress can and should be
made.
All of these people, experts in their own ﬁeld, were adamant
that things needed to change; in some instances they felt progress
could be achieved in the short term; but others were perceived as
targeting more fundamental changes that would effectively only
achieve fruition if dealt with over a broader time scale. These
changes would also mean that attitudes within the health care
system and the wider community would need to evolve to sustain
them. How to achieve this? A complex question, I feel, for which no
simple answer could be given. Here, however, is an overview of
discusants’ priorities.
1. Training
This was seen as a vital component of any plans for the future
andwas identiﬁed as needed by all sections of the care professions:
 Medically/professionally qualiﬁed staff in different spheres, i.e.
physiotherapists, occupational therapists, technicians, etc.
 Those people who make up the vast majority of care staff in care
establishments all over the country.
In the medical sphere, specialist training and allocation of
funding is required to providemore neurologists speciﬁcally trained
and specialising in diagnosis and care for the identiﬁed high
population in the UK who are living with and being affected by
epilepsy; and to access the equipment needed.
It would be important to ensure that staffs in all areas of care are
able to access funding, are trained to a high standard and have theE-mail address: mb1950@tesco.net.
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ably care for the different types of client who present with
epilepsy. This would include the population of people with
learning disability, of whom a large percentage have epilepsy as
an integral factor. This would result in speciﬁc and highly
specialised care, the positive effects of which cannot be under-
estimated.
An important suggestion made was that training for all doctors,
nurses and other health professionals should include seminars
given by people in a position to tell the ‘expert professionals’ ‘the
real life’ unexpurgated truth about the everyday highs and lows of
living with the condition. A carer’s view would also be important,
as this would heighten awareness of the difﬁculties that they may
experience by being in that position. This is something that holistic
care is meant to address, but for which there are variable results.
2. Choice
Those individuals living with the condition felt that they
should:
 be an equal party in consultations on their treatments;
 have all aspects of their treatment explained thoroughly;
 should where possible, be able to make independent decisions. If
necessary patients advocates should be used to ensure this is
done and that the individual concerned comprehends the
options; this was seen as of paramount importance by my
discussants.
To achieve this, relevant unbiased information on treatments
should be made available, written in simple terms, and including
information about risks, side effects, long-term implications and
expected outcomes on the individual’s life now and in the future.
3. Medication
It was felt important that treatments which promoted the
dignity and respect of the service user in relation to administration
were promoted. In the short term, this would involve drugs like
buccal Midazolam or an equivalent being licensed in a timely
fashion, obviating use of rectal medications. This mode of
administration was seen by the group as a ‘most intrusive’ and
a ‘socially unacceptable’ practice, although accepted as a ‘neces-
sary evil’. In some areas of the country it is still authorised and
carried out; some hospital trusts will not sanction prescribing in
deference to NICE guidelines and canvassed patient opinion.
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With themain large centres for epilepsy being scattered as they
are around the UK, patients requiring specialist treatment often
have to travel extensively to access the expertise they need. While
these centres offer excellent facilities, travelling great distances
was deemed unacceptable and in some cases may mean that
choice is eroded.
4. Awareness
In 2010although thingshave improved there is consensus that in
the UK there is still a long way to go in helping the average person
appreciatewhat epilepsy is andhowit affects individuals livingwith
it in their community. Outdated ideas still persist and this extends to
employers and the workplace, education establishments and
schools and more generally in our communities. A lot of work is
carried out by the voluntary specialist epilepsy sector charities and
they are acknowledged as doing a fantastic job, but discussants felt
that until the Government, whichever political party is in power,
gets to gripswith the situation, nothing signiﬁcant will be achieved.
It has been proven that when (as was the case for Dementia) the
government embraces a programme of initiatives to highlight an
individual long-term condition, public expectations are raised and
treatment and funding efforts are improved.
5. Support
With the involvement of the UK NHS and various white papers,
there are avenues available for patients to access support. For
example, the Expert Patient Programme operates in most parts of
the country and plays a large part in supporting those living with a
range of long-term conditions, including epilepsy. Free six-week
courses also encourage/allow them to meet others in the same
position—living with a condition that affects every area of their life
and is long-term. This can be a very positive experience, at the
same time addressing current government guidelines on encour-
aging self-help in such patients.
Carer support is vital as their input, besides saving the country
millions in care costs, also means the person with epilepsy can be
with their family if they choose to and if this is acceptable to all
concerned. Information and sharing of aspects of treatment and
diagnosis are vital. Carers are the link that provides professionals
with the information they need to diagnose and treat the patient in
many situations. It should also be borne in mind that the person
may wish to exercise their right to independent living and this
should also be supported where possible.
If the circumstances dictate an integrated home care service
which is researched and backed up by qualiﬁed well informed and
skilled professionals will make the transition between care and
home a good experience. A ‘joined up’ system of care is the way
forwardwithany illnessor condition. A real challenge for the future!
6. Research
Personally I feel that over the last 30 years (a period which
encompasses my personal treatment and care), great inroads havebeen made into understanding the many aspects of epilepsy—and
this is to be applauded. If one considers aspects of care such as
medication, diagnosis and the classiﬁcation of different types of
seizures, much progress has been made.
Research made possible by interest from drug companies has
meant that a wide variety of drugs have been introduced. This
has been beneﬁcial in eliminating from common use some of the
medications found, retrospectively, to be responsible for
unwelcome long-term effects such as eye problems and
dementia. Conversely, it has brought drugs such as Keppra,
(Leviracetam) Vimpat (Lacosamide) into the therapeutic arena.
In the future, such pharmaceutical interventions will, I would
hope, continue and be of great beneﬁt. Further large scale
surveys and trials, of the sort undertaken in Parkinson’s disease,
would be helpful.
Funding for scanners which can accurately identify damaged
areas of the brain and in some cases allow removal has meant
surgery is providing a safer, cost effective, feasible option. Results
show that signiﬁcant beneﬁts are achievable, allowing an
individual to recapture a relatively normal life. It is research that
has made these innovations possible—and again the future looks
very promising in this direction.
Genetic research and the factors which make individuals more
likely to have epilepsy is ongoing and has the propensity to
highlight information for future generations. I personally think
this is an area that holds the prospect of the most exciting
breakthrough. It was accidental that many great scientiﬁc
breakthroughs were made; and if governments do not fund
research, these risk being lost. Controlled studies replicating
evidence found will not happen where there is a lack of resources
and so potentially valuable data will be lost and valuable
opportunities missed for the person praying for a resolution to
their illness.
To sum up, then, the views of my discussants, I would say that
what is needed for the future is:
 Epilepsy care needs prioritised for each of the 456,000
individuals living with the condition in the UK.
 High-quality care by trained professionals with an interest and
understanding of the condition.
 Adequate funding for research from preferably independent
sources to get unbiased views on drugs, genetics and the best
way forward for care.
 More research into what the individual with epilepsy would like.
 Training for doctors, nurses and other care staff which is of a high
standard and relates to current and future evidence-based
practice.
 An integrated support system for those with epilepsy and their
carers to ensure that it is in line with individual wishes.
Tall orders, maybe, but we can hope that the speed of
developments seen over the next 60 years will be as monumental
as those seen over the last 60—and that epilepsy care will be
transformed in all these areas.
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